Full metadata record
DC Field | Value | Language |
---|---|---|
dc.contributor.author | Hatcher, John M. | - |
dc.contributor.author | Wang, Eric S. | - |
dc.contributor.author | Johannessen, Liv | - |
dc.contributor.author | Kwiatkowski, Nicholas | - |
dc.contributor.author | Sim, Taebo | - |
dc.contributor.author | Gray, Nathanael S. | - |
dc.date.accessioned | 2024-01-19T22:33:25Z | - |
dc.date.available | 2024-01-19T22:33:25Z | - |
dc.date.created | 2021-09-03 | - |
dc.date.issued | 2018-06 | - |
dc.identifier.issn | 1948-5875 | - |
dc.identifier.uri | https://pubs.kist.re.kr/handle/201004/121320 | - |
dc.description.abstract | Cortistatin A is a natural product isolated from the marine sponge Corticium simplex and was found to be a potent and selective inhibitor of CDK8. Many synthetic groups have reported total syntheses of Cortistatin A; however, these syntheses require between 16 and 30 steps and report between 0.012-2% overall yields, which is not amenable to large-scale production. Owing to similarities between the complex core of Cortistatin A and the simple steroid core, we initiated a campaign to design simple, more easily prepared CDK8 inhibitors based on a steroid scaffold that would be more convenient for large-scale synthesis. Herein, we report the discovery and optimization of JH-VIII-49, a potent and selective inhibitor of CDK8 with a simple steroid core that has an eight-step synthesis with a 33% overall yield, making it suitable for large-scale preparation. Using this scaffold, we then developed a bivalent small molecule degrader, JH-XI-10-02, that can recruit the E3 ligase CRL4(cerebion) to promote the ubiquitination and proteosomal degradation of CDK8. | - |
dc.language | English | - |
dc.publisher | AMER CHEMICAL SOC | - |
dc.subject | MEDIATOR COMPLEX | - |
dc.subject | KINASE | - |
dc.subject | TRANSCRIPTION | - |
dc.subject | CORTISTATIN | - |
dc.subject | GENES | - |
dc.subject | DEGRADATION | - |
dc.subject | ELONGATION | - |
dc.subject | ACTIVATION | - |
dc.subject | SRB10/CDK8 | - |
dc.subject | TURNOVER | - |
dc.title | Development of Highly Potent and Selective Steroidal Inhibitors and Degraders of CDK8 | - |
dc.type | Article | - |
dc.identifier.doi | 10.1021/acsmedchemlett.8b00011 | - |
dc.description.journalClass | 1 | - |
dc.identifier.bibliographicCitation | ACS MEDICINAL CHEMISTRY LETTERS, v.9, no.6, pp.540 - 545 | - |
dc.citation.title | ACS MEDICINAL CHEMISTRY LETTERS | - |
dc.citation.volume | 9 | - |
dc.citation.number | 6 | - |
dc.citation.startPage | 540 | - |
dc.citation.endPage | 545 | - |
dc.description.journalRegisteredClass | scie | - |
dc.description.journalRegisteredClass | scopus | - |
dc.identifier.wosid | 000435613500006 | - |
dc.identifier.scopusid | 2-s2.0-85048541051 | - |
dc.relation.journalWebOfScienceCategory | Chemistry, Medicinal | - |
dc.relation.journalResearchArea | Pharmacology & Pharmacy | - |
dc.type.docType | Article | - |
dc.subject.keywordPlus | MEDIATOR COMPLEX | - |
dc.subject.keywordPlus | KINASE | - |
dc.subject.keywordPlus | TRANSCRIPTION | - |
dc.subject.keywordPlus | CORTISTATIN | - |
dc.subject.keywordPlus | GENES | - |
dc.subject.keywordPlus | DEGRADATION | - |
dc.subject.keywordPlus | ELONGATION | - |
dc.subject.keywordPlus | ACTIVATION | - |
dc.subject.keywordPlus | SRB10/CDK8 | - |
dc.subject.keywordPlus | TURNOVER | - |
dc.subject.keywordAuthor | CDK8 | - |
dc.subject.keywordAuthor | CDK19 | - |
dc.subject.keywordAuthor | Cortistatin A | - |
dc.subject.keywordAuthor | kinase inhibitor | - |
dc.subject.keywordAuthor | mediator complex | - |
dc.subject.keywordAuthor | PROTAC | - |
dc.subject.keywordAuthor | Cereblon | - |
dc.subject.keywordAuthor | E3 ligase | - |
dc.subject.keywordAuthor | degradation | - |
Items in DSpace are protected by copyright, with all rights reserved, unless otherwise indicated.